Diabetes Market 2022
Language:
Japanese
Product Code No:
C64101700
Issued In:
2022/05
#of Pages:
188
Publication Cycle:
Biannual
Format:
PDF
Geographic Coverage:
Japan
Industry:
Coverage: (Product/service)
Diabetes drugs, examination and food:
Research Target:
Manufacturers of diabetes examination devices, food for diabetes, governmental agencies, and etc.
Research Content:
I Diabetes Market Overview
- Outline of Diabetes
1) Pathogenic mechanism of diabetes
2) Categorization of diabetes
3) Diabetes tests
4) How to understand complexed diseases and hammering out of diagnostic criteria
5) Diagnosis of diabetes
6) Treatment of diabetes
7) Complications of diabetes
8) Status of diabetes patients (medical expenses, number of patients)
9) Diabetes and Sarcopenia & Frailty - Outline of Diabetes Market
1) Trends of market players
2) List of market size
3) Examination/Diagnosis market
4) Therapeutic drugs market - Market Size Forecast for 2024
- Future Market Outlook
II Diabetes Prevention (Food) Market
- Diet Therapy and Exercise Therapy
- Diet Therapy Outline
1) Combined food for diabetes patients
2) FOSHU (Food for Specified Health Uses)
3) Low-calorie sweeteners - Product Trends
1) Combined food for diabetes patients
2) FOSHU (Food for Specified Health Uses)
3) Low-calorie sweeteners - Market Perspectives
III Diabetes Examination and Diagnosis Market
- Diabetes Diagnosis and Self-Monitoring of Blood Glucose (SMBG)
- Market Size
- Market Trends
A: Apparatuses for measuring blood sugar level
B: Apparatuses for measuring urine sugar level, dip stick method for urinary sugar - Trends of Continuous Glucose Monitoring (CGM) System
- Market Size Forecast for 2024
IV Therapeutic Drugs Market
- Market Overview
- Market Size
- Market Share by Company
- Market Size and Market Share by Therapeutic Drug
1) Insulin release stimulator (sulfonylurea)
2) Insulin release stimulator (fast-acting insulin release stimulator)
3) Insulin resistance improver (biguanide)
4) Insulin resistance improver (thiazolidine)
5) alpha-glucosidase inhibitor
6) DPP4 inhibitor
7) GLP-1 receptor
8) SGLT2 inhibitor - Hypoglycemic Agent
- Insulin Preparation
- Diabetes Complication Drug
- Market Size Forecast for 2024